BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015;8:437-444. [PMID: 25709477 DOI: 10.2147/ott.s76048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhao K, Huang Z, Si Y, Sun L, Yu J, Meng X. Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus. Cancer Manag Res 2021;13:613-23. [PMID: 33531834 DOI: 10.2147/CMAR.S278914] [Reference Citation Analysis]
2 Wang Y, Liu JF. A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus. Onco Targets Ther 2017;10:2453-9. [PMID: 28503068 DOI: 10.2147/OTT.S115637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Ji A, Jin R, Zhang R, Li H. Primary small cell carcinoma of the esophagus: progression in the last decade. Ann Transl Med 2020;8:502. [PMID: 32395546 DOI: 10.21037/atm.2020.03.214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Alfayez M. Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities. World J Clin Oncol 2020; 11(10): 836-843 [PMID: 33200076 DOI: 10.5306/wjco.v11.i10.836] [Reference Citation Analysis]
5 Fan N, Wang Z, Huang Y, Tan Z, Yang H, Lin P. A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery. Cancer Control 2021;28:10732748211027147. [PMID: 34155924 DOI: 10.1177/10732748211027147] [Reference Citation Analysis]
6 Miao H, Li R, Chen D, Hu J, Chen Y, Wen Z. Survival outcomes and prognostic factors of primary small cell carcinoma of the esophagus. J Thorac Dis 2021;13:2790-802. [PMID: 34164171 DOI: 10.21037/jtd-20-3334] [Reference Citation Analysis]
7 Song Y, Wang W, Tao G, Zhu W, Zhou X, Pan P. Survival benefit of radiotherapy to patients with small cell esophagus carcinoma: an analysis of Surveillance Epidemiology and End Results (SEER) data. Oncotarget 2016;7:15474-80. [PMID: 26943276 DOI: 10.18632/oncotarget.6764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Zhao K, Ma L, Feng L, Huang Z, Meng X, Yu J. CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus. Front Mol Biosci 2020;7:608404. [PMID: 33490104 DOI: 10.3389/fmolb.2020.608404] [Reference Citation Analysis]
9 Jeene PM, Geijsen ED, Muijs CT, Rozema T, Aleman BMP, Muller K, Baas JM, Nuyttens JJ, Wouterse S, Braam PM, Oppedijk V, Ceha HM, Cnossen J, Spruit P, Bongers EM, Berbée M, Mook S, Hulshof MCCM. Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease. Am J Clin Oncol 2019;42:534-8. [PMID: 31021827 DOI: 10.1097/COC.0000000000000546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
10 Liu D, Wen J, Chen J, Fan M, Zhang Z. Nomogram for the prediction of individualized overall survival of patients diagnosed with small cell esophageal carcinoma. Ann Transl Med 2021;9:1344. [PMID: 34532481 DOI: 10.21037/atm-21-3900] [Reference Citation Analysis]